Cargando…
Is heterologous prime-boost COVID-19 vaccination a concern or an opportunity for Ethiopia?
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909475/ https://www.ncbi.nlm.nih.gov/pubmed/36777764 http://dx.doi.org/10.3389/fpubh.2022.1046546 |
_version_ | 1784884582867271680 |
---|---|
author | Gelanew, Tesfaye Wassie, Liya Mulu, Andargachew Wondwossen, Liya Abebe, Markos Mihret, Adane Abdissa, Alemseged |
author_facet | Gelanew, Tesfaye Wassie, Liya Mulu, Andargachew Wondwossen, Liya Abebe, Markos Mihret, Adane Abdissa, Alemseged |
author_sort | Gelanew, Tesfaye |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9909475 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-99094752023-02-10 Is heterologous prime-boost COVID-19 vaccination a concern or an opportunity for Ethiopia? Gelanew, Tesfaye Wassie, Liya Mulu, Andargachew Wondwossen, Liya Abebe, Markos Mihret, Adane Abdissa, Alemseged Front Public Health Public Health Frontiers Media S.A. 2023-01-26 /pmc/articles/PMC9909475/ /pubmed/36777764 http://dx.doi.org/10.3389/fpubh.2022.1046546 Text en Copyright © 2023 Gelanew, Wassie, Mulu, Wondwossen, Abebe, Mihret and Abdissa. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Public Health Gelanew, Tesfaye Wassie, Liya Mulu, Andargachew Wondwossen, Liya Abebe, Markos Mihret, Adane Abdissa, Alemseged Is heterologous prime-boost COVID-19 vaccination a concern or an opportunity for Ethiopia? |
title | Is heterologous prime-boost COVID-19 vaccination a concern or an opportunity for Ethiopia? |
title_full | Is heterologous prime-boost COVID-19 vaccination a concern or an opportunity for Ethiopia? |
title_fullStr | Is heterologous prime-boost COVID-19 vaccination a concern or an opportunity for Ethiopia? |
title_full_unstemmed | Is heterologous prime-boost COVID-19 vaccination a concern or an opportunity for Ethiopia? |
title_short | Is heterologous prime-boost COVID-19 vaccination a concern or an opportunity for Ethiopia? |
title_sort | is heterologous prime-boost covid-19 vaccination a concern or an opportunity for ethiopia? |
topic | Public Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909475/ https://www.ncbi.nlm.nih.gov/pubmed/36777764 http://dx.doi.org/10.3389/fpubh.2022.1046546 |
work_keys_str_mv | AT gelanewtesfaye isheterologousprimeboostcovid19vaccinationaconcernoranopportunityforethiopia AT wassieliya isheterologousprimeboostcovid19vaccinationaconcernoranopportunityforethiopia AT muluandargachew isheterologousprimeboostcovid19vaccinationaconcernoranopportunityforethiopia AT wondwossenliya isheterologousprimeboostcovid19vaccinationaconcernoranopportunityforethiopia AT abebemarkos isheterologousprimeboostcovid19vaccinationaconcernoranopportunityforethiopia AT mihretadane isheterologousprimeboostcovid19vaccinationaconcernoranopportunityforethiopia AT abdissaalemseged isheterologousprimeboostcovid19vaccinationaconcernoranopportunityforethiopia |